About MusclePharm Corp.
MusclePharm Corporation is a performance lifestyle company. The Company develops, manufactures, markets and distributes branded nutritional supplements. The Company offers a range of powders, capsules, tablets and gels. The Company's portfolio of brands targets various types of fitness enthusiasts, including professional, combat sport, weight training, bodybuilding, running, basketball, soccer, cross fit, golf, tennis, volleyball and other active lifestyle activities. The MusclePharm Sport Series includes supplements that cover the needs of athletes, including their workout needs. MusclePharm Hybrid Series products include Assault, Amino1 and Combat Protein Powder. FitMiss products are designed and formulated for the active woman's lifestyle utilizing ingredients that cover the range of busy women's needs, including weight loss, multi-vitamins, protein shakes, detox, skin care and pre-workout energy mixes. MusclePharm Core products include BCAA 3:1:2, CLA Core and Fish Oil.
Industry, Sector and Symbol:
- Sector: Consumer Staples
- Industry: N/A
- Sub-Industry: N/A
- Exchange: OTCMKTS
- Symbol: MSLP
- CUSIP:
Key Metrics:
- Previous Close: $2.09
- 50 Day Moving Average: $2.17
- 200 Day Moving Average: $2.66
- 52-Week Range: $1.68 - $4.13
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 4.02
- P/E Growth: -0.07
- Market Cap: $28.91M
- Outstanding Shares: 13,834,000
- Beta: 2.62
Profitability:- Net Margins: -31.92%
- Return on Equity: -569.76%
- Return on Assets: -31.19%
Debt:- Current Ratio: 0.69%
- Quick Ratio: 0.58%
Additional Links:
Companies Related to MusclePharm Corp.:
Consensus Ratings for MusclePharm Corp. (OTCMKTS:MSLP) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for MusclePharm Corp. (OTCMKTS:MSLP)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 11/4/2014 | Wm Smith | Initiated Coverage | Not Rated | $18.00 |  |
(Data available from 9/29/2014 forward)
Earnings History for MusclePharm Corp. (OTCMKTS:MSLP)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/7/2016 | | | | | | | | |
| 8/9/2016 | | ($0.03) | ($0.19) | | | View | N/A | |
| 8/10/2015 | | ($0.19) | ($0.51) | | | View | N/A | |
| 5/11/2015 | | ($0.26) | ($0.56) | | | View | N/A | |
| 3/16/2015 | | $0.01 | ($1.39) | | | View | N/A | |
| 11/14/2014 | | ($0.02) | ($0.31) | | | View | N/A | |
| 8/4/2014 | | ($0.08) | $0.03 | | | View | N/A | |
| 3/31/2014 | | ($0.50) | ($0.51) | | | View | N/A | |
| 8/14/2013 | | | ($0.34) | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for MusclePharm Corp. (OTCMKTS:MSLP)Current Year EPS Consensus Estimate: $-1.03 EPS
Next Year EPS Consensus Estimate: $0.52 EPS
Dividend History for MusclePharm Corp. (OTCMKTS:MSLP)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for MusclePharm Corp. (OTCMKTS:MSLP)Insider Ownership Percentage: 27.00%
Institutional Ownership Percentage: 7.35%
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 11/24/2014 | Andrew J Lupo | Director | Buy | 16,010 | $10.62 | $170,026.20 | |
| 11/20/2014 | Andrew J Lupo | Director | Buy | 2,200 | $10.10 | $22,220.00 | |
| 11/20/2014 | Brad J Pyatt | CEO | Buy | 9,900 | $10.09 | $99,891.00 | |
| 11/20/2014 | James J Greenwell | COO | Buy | 1,000 | $9.90 | $9,900.00 | |
| 9/19/2014 | Gregory Macosko | Director | Buy | 1,000 | $13.21 | $13,210.00 | |
| 8/22/2014 | Brad J Pyatt | CEO | Buy | 5,358 | $12.15 | $65,099.70 | |
| 8/14/2014 | Brad J Pyatt | CEO | Buy | 2,500 | $11.48 | $28,700.00 | |
| 8/8/2014 | Brad J Pyatt | CEO | Buy | 15,000 | $11.27 | $169,050.00 | |
| 8/8/2014 | James J Greenwell | COO | Buy | 1,000 | $11.00 | $11,000.00 | |
| 5/12/2014 | Michael J Doron | Director | Buy | 1,000 | $10.14 | $10,140.00 | |
| 5/8/2014 | Richard Estalella | President | Buy | 10,000 | $9.80 | $98,000.00 | |
| 12/6/2013 | Richard Estalella | COO | Buy | 7,000 | $8.06 | $56,420.00 | |
| 12/5/2013 | Brad J Pyatt | CEO | Buy | 11,554 | $8.05 | $93,009.70 | |
| 12/5/2013 | Lewis Gary Davis | CFO | Buy | 2,000 | $7.97 | $15,940.00 | |
| 12/5/2013 | Sydney R Rollock | CMO | Buy | 8,335 | $8.11 | $67,596.85 | |
| 11/27/2013 | Brad J Pyatt | CEO | Buy | 8,800 | $8.48 | $74,624.00 | |
| 11/26/2013 | Lewis Gary Davis | CFO | Buy | 1,000 | $8.30 | $8,300.00 | |
| 11/22/2013 | Richard Estalella | COO | Buy | 3,000 | $8.30 | $24,900.00 | |
| 11/22/2013 | Sydney R Rollock | CMO | Buy | 5,000 | $8.25 | $41,250.00 | |
| 11/21/2013 | Brad J Pyatt | CEO | Buy | 4,950 | $8.19 | $40,540.50 | |
(Data available from 1/1/2013 forward)
Latest Headlines for MusclePharm Corp. (OTCMKTS:MSLP)| Date | Headline |
|---|
 | MUSCLEPHARM CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial State (OTCMKTS:MSLP)
biz.yahoo.com - September 27 at 6:06 PM |
 | MusclePharm Raises More Than $60,000 at First Annual Submit Cancer Jiu-Jitsu Charity Event (OTCMKTS:MSLP)
www.broadwayworld.com - September 23 at 5:51 PM |
| MusclePharm Raises $60,000+ at First Annual Submit Cancer Jiu-Jitsu Charity Event (OTCMKTS:MSLP)
finance.yahoo.com - September 23 at 10:54 AM |
 | MusclePharm Corp. :MSLP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016 (OTCMKTS:MSLP)
www.capitalcube.com - August 16 at 6:26 PM |
| MusclePharm Reports 2016 Second Quarter Monetary Outcomes. South Carolina SC (OTCMKTS:MSLP)
www.southcarolinasc.com - August 9 at 6:33 PM |
| MUSCLEPHARM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (OTCMKTS:MSLP)
biz.yahoo.com - August 9 at 6:33 PM |
| MUSCLEPHARM CORP Files SEC form 10-Q, Quarterly Report (OTCMKTS:MSLP)
biz.yahoo.com - August 9 at 6:33 PM |
| MusclePharm Reports 2016 Second Quarter Financial Results (OTCMKTS:MSLP)
finance.yahoo.com - August 9 at 6:33 PM |
| MUSCLEPHARM CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (OTCMKTS:MSLP)
biz.yahoo.com - June 29 at 4:21 PM |
| MusclePharm Corporation Announces More Than $45 Million in Future Commitments Trimmed To Date (OTCMKTS:MSLP)
finance.yahoo.com - May 26 at 4:15 PM |
| MUSCLEPHARM CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (OTCMKTS:MSLP)
biz.yahoo.com - May 26 at 4:08 PM |
| MusclePharm Corp. :MSLP-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 (OTCMKTS:MSLP)
www.capitalcube.com - May 26 at 10:47 AM |
| MUSCLEPHARM CORP Files SEC form 8-K, Termination of a Material Definitive Agreement (OTCMKTS:MSLP)
biz.yahoo.com - May 25 at 4:24 PM |
| MusclePharm Reports 2016 First Quarter Financial Results (OTCMKTS:MSLP)
finance.yahoo.com - May 10 at 5:38 PM |
| MUSCLEPHARM CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (OTCMKTS:MSLP)
biz.yahoo.com - February 16 at 5:17 PM |
| MUSCLEPHARM CORP Files SEC form 8-K, Other Events (OTCMKTS:MSLP)
biz.yahoo.com - February 12 at 5:30 PM |
| MusclePharm Focused on Expanding Market Share in Growing Protein Sector (OTCMKTS:MSLP)
finance.yahoo.com - January 19 at 8:15 AM |
| MusclePharm Completes $10 Million Financing (OTCMKTS:MSLP)
finance.yahoo.com - January 14 at 8:00 AM |
| MUSCLEPHARM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial (OTCMKTS:MSLP)
biz.yahoo.com - January 14 at 7:51 AM |
| MUSCLEPHARM CORP Files SEC form 8-K, Change in Directors or Principal Officers (OTCMKTS:MSLP)
biz.yahoo.com - January 6 at 8:01 AM |
| MusclePharm Corp. Earnings Analysis: Q3, 2015 By the Numbers (OTCMKTS:MSLP)
www.capitalcube.com - December 11 at 10:53 AM |
| MusclePharm Executive Chairman Issues Letter to Shareholders (OTCMKTS:MSLP)
finance.yahoo.com - December 10 at 8:00 AM |
| MUSCLEPHARM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Oblig (OTCMKTS:MSLP)
biz.yahoo.com - December 10 at 6:07 AM |
| MUSCLEPHARM CORP Financials (OTCMKTS:MSLP)
finance.yahoo.com - December 8 at 1:17 PM |
| MUSCLEPHARM CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (OTCMKTS:MSLP)
biz.yahoo.com - November 17 at 8:03 AM |
| MusclePharm to Explore Sale of Its BioZone Laboratories Nevada Subsidiary’s Business (OTCMKTS:MSLP)
finance.yahoo.com - November 17 at 8:00 AM |
| MusclePharm Reports 2015 Third Quarter Financial Results (OTCMKTS:MSLP)
finance.yahoo.com - November 9 at 4:46 PM |
| MUSCLEPHARM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financial (OTCMKTS:MSLP)
biz.yahoo.com - November 9 at 4:43 PM |
| Q3 2015 MusclePharm Corp Earnings Release - After Market Close (OTCMKTS:MSLP)
biz.yahoo.com - November 9 at 7:07 AM |
| MusclePharm Schedules 2015 Third Quarter Financial Results (OTCMKTS:MSLP)
finance.yahoo.com - November 5 at 3:44 PM |
| MUSCLEPHARM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement (OTCMKTS:MSLP)
biz.yahoo.com - October 16 at 4:32 PM |
| Hynes Keller & Hernandez, LLC Announces Investigations of AAC Holdings, Inc., Muscle Pharm Corp., and Hill International, Inc. (OTCMKTS:MSLP)
finance.yahoo.com - September 23 at 7:35 AM |
MusclePharm Corp. (OTCMKTS:MSLP) Chart for Thursday, September, 29, 2016
